For: | Chen RF, Li ZH, Kong XH, Chen JS. Effect of mutated IκBα transfection on multidrug resistance in hilar cholangiocarcinoma cell lines. World J Gastroenterol 2005; 11(5): 726-728 [PMID: 15655831 DOI: 10.3748/wjg.v11.i5.726] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/726.htm |
Number | Citing Articles |
1 |
Makrem Ben Reguiga, Laurence Bonhomme-Faivre, Robert Farinotti. Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-α in rats. Journal of Pharmacy and Pharmacology 2007; 59(3): 401 doi: 10.1211/jpp.59.3.0010
|
2 |
Xiao-Long Hou, Kyoko Takahashi, Ken Tanaka, Katsuhiko Tougou, Feng Qiu, Katsuko Komatsu, Koichi Takahashi, Junichi Azuma. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. International Journal of Pharmaceutics 2008; 358(1-2): 224 doi: 10.1016/j.ijpharm.2008.03.010
|
3 |
Bingyan Liu, Shuo Yan, Yiping Jia, Jun Ma, Shaoqiu Wu, Yuyao Xu, Mingyi Shang, Aiwu Mao. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF‐κB pathway‐mediated inflammatory responses. The FEBS Journal 2016; 283(20): 3839 doi: 10.1111/febs.13894
|
4 |
Sabrina C. Wentz, Michele T. Yip-Schneider, Earl A. Gage, Romil Saxena, Sunil Badve, C. Max Schmidt. Sulindac Prevents Carcinogen-Induced Intrahepatic Cholangiocarcinoma Formation In Vivo. Journal of Surgical Research 2009; 157(1): e87 doi: 10.1016/j.jss.2008.10.006
|
5 |
Wenjiao Li, Ming Li, Xinhui Su, Liping Qin, Mengmeng Miao, Chundong Yu, Yuemao Shen, Qi Luo, Qiang Chen. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway. Biochimie 2014; 101: 183 doi: 10.1016/j.biochi.2014.01.012
|
6 |
S Gordon, G Akopyan, H Garban, B Bonavida. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006; 25(8): 1125 doi: 10.1038/sj.onc.1209080
|
7 |
Steven J. Cohen, Paul F. Engstrom, Nancy L. Lewis, Corey J. Langer, Susan McLaughlin, Mary Beard, Louis M. Weiner, Neal J. Meropol. Phase I Study of Capecitabine and Oxaliplatin in Combination With the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology 2008; 31(1): 1 doi: 10.1097/COC.0b013e31805c142f
|